These cytokines, particularly TNF-α, play a key role in activating inflammatory pathways within the liver, contributing to the damage of hepatocytes (liver cells) and promoting the development of NAFLD, especially when progressing to the more severe stage known as non-alcoholic steatohepatitis (NASH). This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.